Press release
United States Digital Therapeutics for Diabetes Market 2025 | Growth Drivers, Key Players & Opportunities
Digital Therapeutics for Diabetes Market
Digital Therapeutics for Diabetes Market reached US$ 1.6 billion in 2023 and is expected to reach US$ 5.3 billion by 2033, growing at a CAGR of 12.9% during the forecast period 2025-2033.
Key Development:
United States: Recent Industry Developments
✅ In September 2025, Amazon partnered with nutrition care startup Fay to offer personalized, insurance-covered dietitian services through its digital health platform.
✅ In July 2025, Omada Health launched a digital therapeutics program for diabetes management integrating AI-driven lifestyle coaching.
✅ In June 2025, Omada Health went public with a $1.1 billion valuation, marking a significant milestone in digital health.
Japan: Recent Industry Developments
✅ In August 2025, Sumitomo Pharma partnered with a U.S. digital therapeutics startup to co-develop AI-driven diabetes management solutions.
✅ In July 2025, Omron Healthcare launched a digital therapeutics program for diabetes management using connected devices and mobile apps.
✅ In May 2025, Mitsubishi Tanabe Pharma acquired a domestic diabetes digital therapeutics company to expand its remote care offerings.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/digital-therapeutics-for-diabetes-market?sb
Digital Therapeutics for Diabetes are evidence-based software programs and apps designed to prevent, manage, or treat diabetes by supporting lifestyle modifications, glucose monitoring, medication adherence, and personalized care plans. They empower patients with real-time feedback, remote monitoring, and data-driven interventions alongside traditional medical therapies.
Recent Mergers and Acquisitions
United States: Recent Mergers & Acquisitions
✅ In August 2025, Roche partnered with a U.S.-based digital health startup to co-develop next-generation diabetes digital therapeutics. The collaboration focuses on AI-enabled glucose management, strengthening Roche's digital health and patient support portfolio.
✅ In May 2025, Johnson & Johnson acquired a minority stake in a diabetes digital therapeutics company to expand its remote patient monitoring capabilities. The acquisition enhances R&D and integration of digital care solutions, targeting improved adherence and outcomes.
Key Players:
-> Welldoc, Inc., Omada Health Inc., Glooko, Inc., Azumio Inc., Abbott Laboratories, mySugr GmbH, Dexcom, Inc., Health2Sync, iHealth Labs Inc., Medtronic plc and among others
Growth Forecast Projected:
The Global Digital Therapeutics for Diabetes Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2033. In 2024, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.
Research Process:
Both primary and secondary data sources have been used in the global Digital Therapeutics for Diabetes Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=digital-therapeutics-for-diabetes-market
Key Segments:
➥ By Product Type: Software Solutions, Mobile Apps, Web-Based Solutions, Hardware Solutions, Wearable Devices, Continuous Glucose Monitors, Others
➥ By Application: Type-1 Diabetes, Type-2 Diabetes, Pre-Diabetes
➥ By End User: Hospitals, Specialty Clinics, Homecare Settings, Others
Regional Analysis for Digital Therapeutics for Diabetes Market:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Benefits of the Report:
Chapter 1: Sets the stage by outlining the report's coverage, summarizing key market segments by region, product type, and application. Presents a snapshot of market sizes, growth potential across segments, and anticipated industry evolution both short and long term.
Chapter 2: Highlights pivotal market insights and uncovers the most significant emerging trends driving change within the industry.
Chapter 3: Offers an in-depth look at the competitive landscape among Digital Therapeutics for Diabetes producers, including revenue shares, strategic moves, and recent mergers and acquisitions.
Chapter 4: Presents comprehensive profiles of the market's key players, delving into details such as revenue, profit margins, product portfolios, and company milestones.
Chapters 5 & 6: Analyze Digital Therapeutics for Diabetes revenue at both regional and country levels, providing quantitative breakdowns of market sizes, growth opportunities, and development prospects worldwide.
Chapter 7: Focuses on different market segments by type, examining their individual sizes and potential, guiding readers toward high-impact, untapped market areas.
Chapter 8: Explores segmentation by application, evaluating industry growth potential in various downstream markets and pinpointing promising sectors for expansion.
Chapter 9: Provides a thorough review of the industry's supply chain mapping out both upstream and downstream activities.
Chapter 10: Concludes with a summary of the report's key findings and highlights the most critical takeaways for industry stakeholders.
Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/digital-therapeutics-for-diabetes-market?sb
FAQ
What is the current size of the Digital Therapeutics for Diabetes Market?
A: In 2023, the Digital Therapeutics for Diabetes Market was valued at US$ 1.6 billion , reflecting its strong industry presence.
Q2: How large is the Digital Therapeutics for Diabetes Market expected to be by 2033?
A: By 2033, industry forecasts suggest the Digital Therapeutics for Diabetes Market will grow to around US$ 5.3 billion, demonstrating significant expansion.
Q3: What is the growth rate of the Digital Therapeutics for Diabetes Market?
A: The market is projected to expand at a compound annual growth rate (CAGR) of 12.9% during the forecast period from 2025 to 2033.
Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?sb
Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring
Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?sb
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release United States Digital Therapeutics for Diabetes Market 2025 | Growth Drivers, Key Players & Opportunities here
News-ID: 4188146 • Views: …
More Releases from DataM intelligence 4 Market Research LLP
United States Wine Packaging Market to hit US$ 7.9 billion by 2030 | Major Marke …
"Global Wine Packaging Market reached US$ 5.1 billion in 2022 and is expected to reach US$ 7.9 billion by 2030, growing with a CAGR of 5.6% during the forecast period 2023-2030." As per DataM intelligence research report
Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/wine-packaging-market?sp
United States: Recent Industry Developments
✅ In August 2025, Ball Corporation launched a sustainable wine packaging solution using lightweight aluminum bottles designed to reduce…
United States Injection In-Mold Labels Market to hit US$ 4.79 billion by 2032 | …
"Injection In-Mold Labels Market reached US$ 3.21 billion in 2024 and is expected to reach US$ 4.79 billion by 2032, growing with a CAGR of 5.13% during the forecast period 2025-2032." As per DataM intelligence research report
Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/injection-in-mold-labels-market?sp
United States: Recent Industry Developments
✅ In August 2025, Avery Dennison launched a new line of injection in-mold labels designed for durable packaging and…
United States Internet of Medical Things (IoMT) Market 2025 | Growth Drivers, Ma …
Market Size and Growth
The global Internet of Medical Things (IoMT) market reached US$ 49.82 billion in 2023 and is expected to reach US$ 459.78 billion by 2031, growing at a CAGR of 32.3% during the forecast period 2024-2031.
Recent Mergers and Acquisitions Key Development:
United States: Recent Industry Developments
✅ In July 2025, HealthTech Solutions acquired IoMT Innovations for $300 million, consolidating its position in the IoMT market and expanding its portfolio of…
United States Customer Engagement Solutions Market Expansion Fueled by AI & Omni …
Global Customer Engagement Solutions Market reached USD 19.1 billion in 2022 and is expected to reach USD 33.2 billion by 2030, growing with a CAGR of 10.7% during the forecast period 2023-2030.
The Customer Engagement Solutions market analysis by DataM Intelligence delivers authoritative insights into the sector's growth, offering geographic coverage, demand outlook, and strategic trends that highlight both regional dominance and emerging opportunities. Beyond a surface-level overview, the research explores…
More Releases for Diabetes
Major Force in the Diabetes Pen Market 2025: Diabetes Fuels Surge In Demand For …
How Will the Diabetes Pen Market Grow, and What Is the Projected Market Size?
The diabetes pen market is projected to grow from $29.24 billion in 2024 to $31.22 billion in 2025, at a CAGR of 6.8%. Growth is fueled by the rising need for managing diabetes, advancements in diabetes care, and an increasing focus on patient-friendly medication administration tools.
The diabetes pen market is projected to grow strongly, reaching $40.17 billion…
Diabetes Monitoring Devices Market: Regaining Its Glory| Ascensia Diabetes Care, …
The Latest Study Published by HTF MI Research on the "Diabetes Monitoring Devices Market'' evaluates market size, trend and forecast to 2029. The Diabetes Monitoring Devices market study includes significant research data and evidences to be a practical resource document for managers and analysts is, industry experts and other key people to have an easily accessible and self-analysed study to help understand market trends, growth drivers, opportunities and upcoming challenges…
Prevalence of Diabetes Drives Opportunities for Type-2 Diabetes Market
The Type-2 Diabetes Market Analysis, 2023, by MarkNtel Advisors, presents a well-researched, detail-driven, and accurate study for the stakeholders. This analysis entails prominent aspects like trends, & recent developments, drivers, opportunities, challenges, & restraints, among other parameters, influencing the overall industry expansion across different locations. This report comprises data from historic years (2018-21) & the base year (2022) to put together an estimation of the forecast period (2023-28).
According to Type-2 Diabetes Market…
Reverse Diabetes with Dr. Merritt’s Diabetes Reversal Recipe
[November 26, 2020] – People suffering from diabetes always search for ways to lower blood sugar levels in their bodies. Diabetes treatment available costs you hundreds of dollars yearly and also restricts you to a diabetic diet. That hampers your mental health and well-being. Apart from this, eye problems, kidney failure, amputations are some of the physical problems diabetic patients face.
Dr. Marlene Merritt (from the Merritt Wellness Center in…
Diabetes Treatment
Diabetes Treatment is a important way to help manage the healthy ,easy to use and improve the way of the treatment of blood glucose monitoring system.
As living standards improve, an increasing obesity, the Diabetes Treatment has improved peoples living habits, disease control effect, is becoming more and more important.
The global Diabetes Treatment market is valued at 43700 million US$ in 2018 and will reach 58000 million US$ by the end…
Self-Monitoring Blood Glucose Devices Market Study by Advance Application [Type …
The global self-monitoring blood glucose devices market was valued at $7,768 million in 2017 and is projected to reach $10,828 million by 2025 at a CAGR of 4.2% from 2018 to 2025. Monitoring of blood glucose is an essential step in diabetes management. Blood glucose monitoring devices are predominantly used to monitor a patient’s blood glucose level. Self-monitoring blood glucose (SMBG) devices are easy-to-use and enable people to monitor their…
